Download car parking/transport

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Senior Clinical Fellow in Cross Sectional Radiology
Person Specification
Job Description
Terms and Conditions
****
PERSON SPECIFICATION
POST:
Senior Clinical Fellow in Cross Sectional Radiology
BASE:
The Christie, Withington, South Manchester
_____________________________________________________________________
REQUIREMENTS
ESSENTIAL
DESIRABLE
_____________________________________________________________________
QUALIFICATIONS
HIGHER
TRAINING &
EXPERIENCE
Year 5 post FRCR / Year 6 post CCT
Fifth year radiology SpR or more senior.
Experience in general radiology,
cross sectional imaging and
basic interventional radiology
Experience in general radiology,
cross sectional imaging and
basic interventional radiology
Experience in teaching
under- and postgraduates
ACADEMIC
ACHIEVEMENTS
Record of
research relevant to
radiology
PERSONAL SKILLS
Flexibility, commitment and
compatibility with colleagues
and staff in the department.
Recent publications
in peer-reviewed
journals
PERSONAL
Reliable work record
CIRCUMSTANCES
In good health
_______________________________________________________________
The Post
This is a Senior Clinical Fellow post, 40 hours per week, funded by the Trust. It is based at
the The Christie NHS Foundation Trust.
Duties of the Post
The post is for one year.
The post is principally to obtain specific education and training in specialist cancer imaging
with the opportunity to tailor interests as preferred in functional imaging (MRI and PET-CT)
and/or interventional radiology (diagnostic fluoroscopy and vascular and non vascular
intervention).
There is a significant proportion of time dedicated to research and audit that should lead to
publications in journals, as well as presentations at national and international meetings.
It is anticipated that the post will provide the opportunity to develop experience in Research
Methodology as well as Clinical Governance, administration and management issues
important for appointment as a Consultant Radiologist.
The post holder’s routine clinical work will initially be closely supervised but he/she will
practice increasingly independently as his/her experience develops during the year. In turn,
the post holder will be able to supervise Junior Radiologists as time and expertise progress.
Professional Development:
The post holder will undertake CPD in line with the recommendations of the Royal College
of Radiologists. He /she will make appropriate arrangements for study leave with colleagues
and non-medical staff. Study leave will be limited to 10 days per year.
Teaching Commitment:
The department is active in teaching at SpR level, with further commitments to national and
regional radiology teaching. Medical student, SHO and non-radiology SpR teaching is also
supported. The post holder will undertake lectures and tutorials to medical and non-medical
staff in collaboration with and independent of colleagues.
Multi-disciplinary team meetings:
Numerous MDT meetings take place. The up to date list is published on the Christie
Radiology intranet site. The post holder will lead MDTs, initially with guidance and
subsequently independently.
Clinical Governance:
The post-holder will be expected to participate in all relevant aspects of clinical governance,
including maintaining and improving protocols, the consent process, discrepancy reporting,
guidelines and clinical audit in conjunction with the other staff in the department.
In addition opportunities will exist to get involved with national audit programmes of the
British Society of Interventional Radiology (BSIR).
Office and Secretarial:
The Trust will endeavour to provide office accommodation, but this may be shared
office space with other radiology SpRs. Secretarial support is mostly shared.
PROVISIONAL ACTIVITY TIMETABLE
As agreed with the clinical director Dr Bramley, educational supervisors, Dr Paul Hulse and Dr
Suzie Bonington and research lead Dr Ben Taylor. The exact timetable depends on the skills
and desires of the successful candidate and secondarily upon the needs of the department.
The post will be offered as 40 hours per week, divided into 28 hours of Direct Clinical Care
and 12 hours of Supporting Activity. Documentary evidence including a diary will be kept for
the use of the 12 hours of supporting activity per week. The proposed timetable is attached
(each session lasting 4 hours); note that the actual clinical sessions will be allocated based on
the skill of the successful candidates and requirements of the department. There is also the
opportunity to do additional paid cross sectional reporting sessions subject to demand.
AM
PM
Monday Tuesday
Research functional
imaging
(MR/PET)
Research functional
imaging
(MR/PET)
Wednesday
US/XR
CT
Thursday
functional
imaging
(MR/PET)
CT
Friday
Study
CT
TERMS AND CONDITIONS OF SERVICE
It is desirable that at the commencement of the post the appointee will have obtained or be
within 12 months of obtaining CCT in radiology.
PAY
Salary will be fixed at £50,000 p.a.
CONFIDENTIALITY
The post-holder must maintain the confidentiality of information about patients, staff
and other health service business.
HEALTH AND SAFETY
Employees must be aware of the responsibilities placed on them under the Health &
Safety at Work Act (1974), to ensure that the agreed safety procedures are carried
out to maintain a safe environment for employees.
RISK MANAGEMENT
All staff have a responsibility to report all clinical and non-clinical accidents or
incidents promptly and when requested to co-operate with any investigation
undertaken.
EQUAL OPPORTUNITIES
The Trust has adopted an equal opportunities policy and it is the duty of every
employee to comply with the detail and spirit of the policy
CONFLICT OF INTEREST
The Trust is responsible for the service for the patients in its care meets the highest
standards. Equally, it is responsible for ensuring that staff do not abuse their official
position to gain or to benefit their family or friends.
The Trust’s standing orders require any officer to declare any interest, direct or
indirect with contracts involving the Trust. Staff are not allowed to further their
private interest in the course of their NHS duties.
NO SMOKING
The Trust operates a no smoking policy. Anyone who wishes to smoke may do so
only in one of the designated smoking areas at a time agreed with their line
manager.
MEDICAL EXAMINATION
All appointments with The Christie NHS Foundation Trust are subject to preemployment health screening.
CAR PARKING/TRANSPORT
Car parks for staff are on site, depending on availability of permits.
INFORMAL VISITS
Informal visits are welcome and interested candidates should visit the department by
arrangement with:
Dr Rhidian Bramley
Consultant Radiologist –Director of Service
Department of Radiology
The Christie NHS Foundation Trust
Wilmslow Road
Manchester M20 4BX
Tel: 0161 446 8109
Dr Soo Mak
Consultant Radiologist
Department of Radiology
The Christie NHS Foundation Trust
Wilmslow Road
Manchester M20 4BX
Tel: 0161 918 7128
Dr Prakash Manoharan
Consultant Radiologist
Department of Radiology
The Christie NHS Foundation Trust
Wilmslow Road
Manchester M20 4BX
Tel: 0161 918 7128
Clinical Service
The Radiology Directorate has a departmental budget of £5 million (2011-12).
The Department is spread across four areas:
In the Pat Seed Department are the MR and CT scanners, and there are 3 CT and 2 MR
machines.
General Ultrasound and Interventional Radiology and Fluoroscopy are based in Radiology II,
General Radiography (including digital radiography) is in Radiology I.
There is an Office Suite housing secretaries, Consultant Radiologists, Superintendent
Radiographers and a Staff Room.
The Nuclear Medicine department is in Palatine House where Clinical and Research PET-CT
and conventional Nuclear Medicine Imaging occur.
The new RIS went live in February 2007.
PACS went live in March 2007.
Radiology Examination Totals 2007-08 to 2011-12.
Activity –Totals by patient attendance Radiology Specialty
2007-08
2008-09
2009-10
2010-11
2011-12
CT
MR
PET
9316
10389
10541
12089
12864
3449
3886
4035
4511
4758
1562
1956
2677
2400
3000
Plain
Film
16139
15871
16259
15010
15017
US
2349
2283
2563
2393
2550
Nuclear
Medicine
1650
1692
1910
1921
1815
Fluoroscopy
220
284
273
350
434
Fluoroscopy
Interventional
261
264
224
410
583
Angiography
50
64
61
100
120
In addition the Radiology Department incorporates the nurse-led Day case Procedure Team,
which sites around 1400 central lines per year and is in the process of developing an open
access paracentesis service.
Staff and Management Structure
The Department management structure is as follows:
Medical:
Clinical Director with overall departmental responsibility, lead consultants in CT, MR,
US, Interventional Radiology, Nuclear Medicine, General Radiology, Clinical Audit and
Information Technology. The clinical tutor has responsibilities for registrar training
and assessment. Day-to-day operational issues are dealt with by the section leads,
as required.
Non-medical:
There is a Radiology Clinical Lead and a Radiology Business Manager, supported by a
radiographic team leader, 4 modality service leads / superintendents and a
Secretarial & Clerical Team leader.
Consultant Staff
Dr
Dr
Dr
Dr
Dr
Dr
Dr
Dr
Dr
Dr
Dr
Dr
Dr
C Barker, Plain Film lead, 6 PA
S Bonington, Ultrasound lead and Clinical Tutor, 8 PA
R Bramley, Director of Services and IT lead, 10 PA
B Carrington, 11 PA
P Hulse, Education, 10 PA
H-U Laasch, Interventional lead, 11 PA
R Kochhar, 11 PA
J Lawrance, Associate Medical Director, 12 PA
S Mak, CT Lead, 10 PA
P Manoharan, MRI Lead and Nuclear Medicine lead, 12.5 PA
D Mullan, 11 PA
M B Taylor, Research lead, 12 PA
F Wong, 6 PA
All consultants hold FRCR qualification. All consultants are radiologists with special
interest in cancer imaging and cross-sectional imaging skills
Junior medical Staff
1 Clinical Fellow in Interventional Radiology
1 Clinical Fellow in Cross Sectional Oncology Imaging
3 senior trainees and 1 junior trainee.
Radiographic and Nursing Staff
1 Clinical Support Services manager
1 Radiographic team leader
4 Superintendent Radiographers/Clinical Specialists
27 Radiographers (23 whole time equivalent)
2 full-time radiology nurses
6 Radiographic Aides
A and C staff
1 Radiology business manager (0.5 whole time equivalent)
4 Secretaries/P.A.’s (3.6 whole time equivalents)
6 Clerical officers (6 whole time equivalent)
Diagnostic Radiology Equipment and Replacement Programme
Equipment
Kodak Digital Chest Unit
GE digital room with
wireless detector
OPG unit
Kodak general digital room
GE digital room with
wireless detector and
advanced application
capability
Phillips digital interventional
equipment including
floating table with bucky
and C-arm, Phillips ceiling
suspended tube and
generator, erect bucky
2 mobile IGE x-ray
machines with AEC
1 mobile IGE AMX4 plus
machine
Siemens C-arm mobile
image intensifier
1 laser imager Radiology II
Installation
Date
April 2007
2012
Replacement
Date
2017
2022
Site
Radiology 1, Rm 4
Radiology 1, Rm 1
2006
June 2007
2012
2016
2017
2022
Radiology 1, Rm 1
Radiology 1, Rm 2
Radiology 2, Rm 2
2008
2015
Radiology 2, Rm 1
2001
2011
Radiology
March 2007
2017
CCU
2004
2014
Radiology
2008
2003
1 Siemens Antares
ultrasound scanner
1 Siemens / Accuson X300
interventional US scanner
1 Siemens Definition 64slice MD-CT scanner
1 Siemens Definition 64slice MD-CT scanner
1 Siemens Sensation 16slice MD-CT scanner
1 Siemens TIM Avanto MRI
scanner
1 Siemens TIM Avanto MRI
scanner
1 Kodak Laser
Imager(CT/MRI)
2007
1 Brachytherapy Theatre Xray GE Compax MPG 80
1 GE STE-8 CT-PET
Scanner
Infinia Hawkeye 4 SPECTCT Gamma Camera-CT
1993
Not for
replacement
2012
Radiology II
Radiology II
2007
2012
Radiology II/ CCU
2010
2017
2010
2017
Pat Seed, CT RTP
Planning
Pat Seed, CT
2005
2012
Pat Seed, CT
2004
2011
Pat Seed, MRI
2005
2012
Pat Seed, MRI
1999
Under review
post PACS
Pat Seed
Department
2007
Nuclear Medicine
2006
Nuclear Medicine
Siemens Ecam Signature
Double Headed Gamma
Camera
2005
Table notes: replacement date overdue in italics
Recommended life of general x-ray equipment = 10 years
Recommended life of CT/MRI scanners = 7 years
Recommended life of ultrasound scanners = 5 years
Nuclear Medicine
GENERAL INFORMATION
Greater Manchester itself is a large consumer and business market in its own right,
with a population of 2.5 million, a workforce of 1.2 million and a GDP of £28 billion
(US $41 billion). This represents around 38% of the regional GDP of £75 billion.




Over 25% of the UK’s motorway network runs through the Greater
Manchester area, placing it within 2 hours´ drive time of 20% of the UK
population - some 12 million people.
Over 2 million people live within a ten-mile (16 km) radius of Manchester and
more than 5 million people within a radius of 30 miles (48 km).
Manchester’s population is multi-cultural and predominantly young - 65% of
the population is under 45 years old.
According to an independent survey of senior executives responsible for
location in more than 500 European companies, Manchester places second of
the top 10 European cities (after London) for its cost and availability of staff.
Ref. http://www.salford.gov.uk/business/bas/demographics.htm
Manchester airport is a large international airport and there are good rail links to the
south and north.
The Christie NHS Foundation Trust
One of Europe’s leading cancer centre’s with exciting and ambitious plans for the
future.
“We care, we discover, we teach”
*
*
*
*
An exceptional reputation for patient care and research, excellent record in
performance and financial management, high profile and huge public support is
behind the Christie’s ambitions to be one of the world’s leading cancer centres.
Foundation Trust status has allowed us to embark on a highly ambitious plan to
expand and develop our patient services, research and education.
*
*
*
*
*
The Christie in Manchester is a specialist NHS cancer trust offering:
 high-quality diagnosis, treatment and care for cancer patients
 world-class research
 education in all aspects of cancer
We are one of the leading cancer centres in Europe - registering around 12,500 new
patients and treating about 40,000 patients every year.
We are the lead cancer centre for the Greater Manchester and Cheshire Cancer
Network, covering a population of 3.2 million. Our medical staff also share their
expertise with colleagues across the region, with our doctors running clinics at 16
other general hospitals.
Because of the specialist services we provide around 15% of our patients are
referred from outside Greater Manchester and Cheshire, and our private patients unit
provides care for people from across the world.
Our patients are referred from district general hospitals, having already had their
cancer diagnosed, and often with complex or rare cancer. Many will also have had
their first treatment, usually surgical, before referral.
Wide range of cancer services
We offer a wide range of services including specialist surgery, chemotherapy,
radiotherapy, palliative and supportive care and endocrinology.
As one of the largest radiotherapy departments in the world we deliver over 80,000
radiotherapy treatments a year. We also annually deliver over 30,000 chemotherapy
treatments and undertake around 3,700 operations every year. We are one of only
two trusts in the country offering surgical treatment for patients with pseudomyxoma
- a very rare type of cancer. Our young oncology unit is one of only eight dedicated
teenage cancer units in the country.
We have 184 inpatient beds, which are intensively used, with an average length of
stay of six days.
Key player in Europe
We are a member of the Organisation of European Cancer Centres (OECI) which
provides a forum for discussion and agreement amongst the leading cancer centres
in Europe as well as coordinating a number of specific projects. The OECI is an
important vehicle for taking forward the concept of comprehensive cancer centres in
Europe. We are the only centre in the UK to be voted onto the OEIC as a member.
Leading clinical trials unit
We also run one of the largest clinical trials units in the country for phase I/II cancer
trials, with around 1,200 patients going on new trials. This is set to double over the
next few years making us one of the largest clinical trials units in the world. Clinical
trials at the Christie are funded by charities such as Cancer Research UK, drug
companies and the national clinical trials network which is made up of the
Department of Health and other key groups. They are the vital step in developing
better treatments for cancer patients and ultimately improving the quality of cancer
care.
Partner in the Manchester Cancer Research Centre
We are a partner in the Manchester Cancer Research Centre with The University of
Manchester, Paterson Institute for Cancer Research and Cancer Research UK. The
Manchester Cancer Research Centre brings together the expertise, ambition and
resources of our organisations and will be one of the world’s leading cancer research
institutes by 2015.
Education
We have a dedicated education unit and provide training for a wide range of pre and
post qualification staff.
Cancer Registry
We manage the North West Cancer Information Service (cancer registry) for the
whole of the North West region.
Manchester Versus Cancer alliance
In partnership with the NHS, local authorities and supporters we have established
the Manchester Versus Cancer alliance to help improve the early detection of cancer.
Research shows that around 500 lives across Greater Manchester could be saved
each year if local people went to their GP early with suspected symptoms.
History
We have achieved world firsts since the Christie was established in 1901. It was
named the Christie in recognition of the pioneering work of both Richard Copley
Christie and his wife Helen Christie. At this time there were 30 beds and 463
patients a year.
Foundation Trust
We became a foundation trust on 1st April 2007. Foundation trust status brings us
new freedoms to further develop our services and greater public accountability.
Funding
We have a total annual turnover of around £170 million. Most of this is from the
NHS, together with income from private patients (around 8%), and from charitable
and research organisations.
Staff
Around 2000 staff and over 300 volunteers work at the Christie.
Awards
Staff teams and individuals have won numerous awards for services and research
over the years, and we were shortlisted for the Health Service Journal’s ‘Acute
Healthcare Organisation of the Year Award 2005’.
Charity
We run the country’s second largest hospital charity in terms of fundraising, with
more than 2000 fundraisers and 20,000 supporters. Our charity contributes about
£11 million a year from fundraising, donations and legacies.
Background
The Christie was formed in 1932 and has grown to be one of the largest cancer
hospitals in Europe. It is the base hospital for the North Western Regional
Department of Clinical Oncology. Along with the Christie Physics and Medical
Engineering, it forms The Christie NHS Foundation Trust. The Paterson Institute for
Cancer Research is adjoins the Trust and has recently been incorporated into
Manchester University. In partnership with Cancer Research UK and Manchester
University the Trust has formed the Manchester Cancer Research Centre (MCRC).
The Trust serves a network population of 3.2 million people (Greater Manchester and
Cheshire), the largest network in the country. The health economy of the Greater
Manchester and Cheshire Cancer Network includes 15 acute and mental health
Trusts. Approximately 20% of patients are referred from outside this network. In
2007-08 there were 12,500 new patients with cancer referred to the trust and
around 180,000 treatments were administered. The Trust has 1,900 staff, 257 beds
and three surgical theatres. A new critical care facility (6 beds with room to expand
to 8 beds) opened in December 2006.
The Trust introduced a new management structure in 2012 in which two Deputy
Chief Operating Officers (DCOO) were appointed. Each DCOO is supported by
clinical Directors of Service. The respective DCOO’s for the two divisions are Ms S
Jenkins and Mr J Dawson. The directors of service for each division are as follows;
Cancer Centre Services
Chief Pharmacist
Critical & Acute Care
Pathology
Radiology
Surgery & Theatres
-
Ms. June So
Mr. Phil Haji-Michael
Dr. Lia Menasce
Dr. Rhidian Bramley
Mr. Malcolm Wilson
-
Dr. John Logue
Position vacant
Dr. Mike Dennis
Dr. Andrew Wardley
Dr. Mike Leahy
Networked Services
Clinical Oncology
Endocrinology
Haematology
Medical Oncology
Young Oncology Services
The Trust has been designated as the cancer centre for the Greater Manchester and
Cheshire Network by Dr C Harrison in a report commissioned by the Strategic Health
Authority (the ‘Harrison report’). Financially the Trust has achieved a surplus for the
past 3 years and a break even position at financial year for the previous 3 years.
The largest clinical department is the Regional Department of Clinical Oncology with
31 consultants which provides a service to The Christie and other hospitals in Greater
Manchester and some in the surrounding region through regular clinics staffed by
consultants. The Director of Service for clinical oncology is Dr J Logue.
There is a University Department of Medical Oncology with 21 consultants. The
Director of Service for medical oncology is Dr A Wardley.
The clinical staff of the trust also includes two physicians with an interest in
Endocrinology and visiting specialist surgeons with interest in plastic, breast, head
and neck, urological, gastro-enterological, ENT and gynaecological surgery, all of
whom have access to beds.
The trust also has dedicated departments of Radiology, Haematology/Oncology,
Epidemiology, Psychological Medicine, Anaesthesiology, Occupational Health and a
Statistics Department, which, in addition to the collection of basic statistics, offers
support to clinicians involved in clinical studies and trials.
Specific disease groups (DGs) comprised of multidisciplinary teams have been active
for 9 years. Their function is to facilitate investigation, treatment and research on
cancers of site specific areas. The DGs are also linked to the Cancer Network Clinical
Subgroups, responsible for ensuring that NICE directives and Improving Outcomes
Guidance are implemented Fourteen such DGs exist in the Trust and pathologists are
members of those groups.
The Christie Physics and Medical Engineering and Bioengineering is situated at the
Christie [Director Dr R Mackay].
The trust has a Medical Library staffed by professional librarians. The range of
services include a modern journal collection, extensive book library and on line
search facilities. The library is also connected with the Internet. A new
postgraduate centre has recently been constructed at The Christie and is now fully
operational.
Attached to the trust is the Paterson Institute of Cancer Research, [Director
Professor N Jones], now part of Manchester University and extensive complex of
laboratories supported by the Cancer Research UK. The Institute is dedicated to
fundamental and clinically orientated cancer research in many fields, including
radiation chemistry, radiobiology, cell population kinetics, molecular biology, tumour
chemotherapy and cytogenetics. Some of these laboratories are involved in joint
collaborative research projects and Clinical Research Fellows have been appointed
between the Institute and the trust.
Research facilities exist in the Paterson Institute for Cancer Research. The
consultant may to negotiate collaborative projects with Professor N Jones, Head of
the PICR.
The Trust Directors are:
Ms C Shaw
Mr R Spencer
Mr I Moston
Dr C Harrison
Ms J Bird
Chief Executive
Chief Operating Officer
Director of Finance and Business Planning
Medical Director
Director of Nursing and Governance